Irving Investors
Investor profile
Venture capital
Irving Investors has backed 3 European tech companies across 3 funding rounds between 2021 and 2026, joining rounds totalling €3.2B. Most active in Cloud and Healthtech. Data as of 4 Nov 2026.
Deals
3
distinct rounds
Companies
3
backed
Active span
2021–2026
6 yrs
Total round €
€3.2B
sum of rounds joined
Deals by year
distinct rounds / yearIrving Investors — deals by year — interactive chart.
Data table
| Irving Investors — deals by year | |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2026 | 1 |
Top sectors
by dealsIrving Investors — top sectors — interactive chart.
Data table
| Irving Investors — top sectors | |
|---|---|
| Cloud | 1 |
| Healthtech | 1 |
| Cybersecurity | 1 |
Stages
by dealsIrving Investors — stages — interactive chart.
Data table
| Irving Investors — stages | |
|---|---|
| Debt | 1 |
| Series C | 1 |
| Other | 1 |
Countries
by dealsIrving Investors — countries — interactive chart.
Data table
| Irving Investors — countries | |
|---|---|
| France | 1 |
| Israel | 1 |
| UK | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- 8090 Industries1
- Apollo1
- Baillie Gifford1
- Castleknight1
- Citadel1
- Context Capital Management1
- Davidson Kempner Capital Management1
- eureKARE1
- Ghisallo1
- Healthcor Management1
- Hudson Bay Capital1
- Javelin Venture Partners1
- Liberty Strategic Capital1
- LionTree1
- Longaeva Partners1
- Neuberger Berman1
- Nvidia1
- Qube Research & Technologies1
- SoftBank Vision Fund 21
- T. Rowe Price Associates1
- the Abu Dhabi Investment Council1
- Third Point Ventures1
- Wellington Partners1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Nscale | UK | 1 | €3.0B |
| Cybereason | Israel | 1 | €233M |
| DNA Script | France | 1 | €31M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Cybereason | Other | €233M | 2021-07 |
| DNA Script | Series C | €31M | 2022-01 |